The goals of Core D (Neuropathology) are to perform postmortem neuropathologic evaluations of participants in the Udall Center. In addition, Core D will provide neuropathologic support to research projects, in particular tau biochemical support and immunohistochemistry for Project 2 , as well as tissue processing and histology for Project 3. Core D will also assist Project 3 with electron microscopic studies. To accomplish these objectives, the specific aims of Core D will:
Specific Aim 1. Perform standardized diagnostic neuropathologic evaluations and data collection on all brains harvested locally or sent to the Udall Center by referring physicians, with particular focus on cases followed by Core B. This will include a) immunostaining of cortical, hippocampal and basal forebrain sections for a-synuclein to record density of Lewy bodies in multiple cortical regions;b) characterizing non-Lewy body Parkinsonian degenerative disorders with immunocytochemistry, including antibodies to tau, TDP-43, ubiquitin, FUS, a-internexin and aB-crystallin, recording estimates of neuronal and glial lesions in neocortex, hippocampus, basal ganglia, thalamus, subthalamic nucleus, midbrain, pons, medulla and cerebellar dentate nucleus for cases with tauopathy;c) assessing Alzheimer type pathology with counts of senile plaques and neurofibrillary tangles in multiple cortical and subcortical areas with thioflavin-S fluorescent microscopy, and assign a Braak neurofibrillary tangle stage on all cases;and d) using validated neuropathologic research criteria for those disorders for which such criteria have been established and "best clinical practice" for uncommon disorders for which research criteria do not yet exist.
Specific Aim 2. Provide frozen human brain samples or DNA to investigators in the Udall Center, particulady Projects 1 and 2, as well as to qualified investigators at other research institutions.
Specific Aim 3. Assist Projects 2 with biochemical studies of tau protein in human brain samples.
Specific Aim 4. Assist Project 3 with neuropathologic characterization of mouse models subjected to drug treatments and with electron microscopic support to evaluate effects of drugs on tau and a-synuclein fibrillization.

Public Health Relevance

The "gold standard" for diagnosis of neurodegenerative disorders, such as Parkinson disease (PD), is neuropathology, which is the medical specialty that uses microscopic evaluation of tissue changes to arrive at a diagnosis. Accurate diagnosis is critical to finding genes and other factors that cause PD, which are the first steps in the process of finding a cure for PD and related disorders.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1-SRB-J)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic Jacksonville
United States
Zip Code
Kertesz, A; Finger, E; Murrell, J et al. (2015) Progressive supranuclear palsy in a family with TDP-43 pathology. Neurocase 21:178-84
Kalia, Lorraine V; Lang, Anthony E; Hazrati, Lili-Naz et al. (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100-5
Sundal, C; Baker, M; Karrenbauer, V et al. (2015) Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. Eur J Neurol 22:328-33
Fujioka, Shinsuke; Sanchez Contreras, Monica Y; Strongosky, Audrey J et al. (2015) Three sib-pairs of autopsy-confirmed progressive supranuclear palsy. Parkinsonism Relat Disord 21:101-5
Bieniek, Kevin F; van Blitterswijk, Marka; Baker, Matthew C et al. (2014) Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia. JAMA Neurol 71:775-81
Bras, Jose; Guerreiro, Rita; Darwent, Lee et al. (2014) Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 23:6139-46
Ross, Jay P; Rayaprolu, Sruti; Bernales, Cecily Q et al. (2014) SLC1A2 rs3794087 does not associate with essential tremor. Neurobiol Aging 35:935.e9-10
Heckman, Michael G; Elbaz, Alexis; Soto-Ortolaza, Alexandra I et al. (2014) Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging 35:266.e5-14
Angeles, Dario C; Ho, Patrick; Chua, Ling Ling et al. (2014) Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila. Hum Mol Genet 23:3157-65
Bailey, Rachel M; Howard, John; Knight, Joshua et al. (2014) Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model. Mol Neurodegener 9:8

Showing the most recent 10 out of 127 publications